Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Nelnet
NNI
$4.89B
| $1.56M | ﹤0.01% |
39,685
-26,298
| -40% | -$919K |
|
|
NXGN
3652
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.56M | ﹤0.01% |
102,564
-260,890
| -72% | -$3.96M |
|
3653
CALL
Alaska Air
ALK
$5.86B
| $1.56M | ﹤0.01% |
19,000
-3,600
| -16% | -$266K |
|
3654
SFL Corp
SFL
$1.61B
| $1.55M | ﹤0.01% |
111,978
+22,821
| +26% | +$307K |
|
3655
Grupo Aval
AVAL
$6.19B
| $1.55M | ﹤0.01% |
200,978
+59,137
| +42% | +$397K |
|
3656
CALL
Neurocrine Biosciences
NBIX
$16.9B
| $1.55M | ﹤0.01% |
39,300
-51,100
| -57% | -$2.03M |
|
|
3657
PUT
Neurocrine Biosciences
NBIX
$16.9B
| $1.55M | ﹤0.01% |
39,300
-10,800
| -22% | -$429K |
|
|
CMO
3658
DELISTED
Capstead Mortgage Corp.
CMO
| $1.55M | ﹤0.01% |
156,950
-285,948
| -65% | -$2.66M |
|
3659
La-Z-Boy
LZB
$1.67B
| $1.55M | ﹤0.01% |
57,961
-6,217
| -10% | -$145K |
|
|
ESV
3660
CALL
DELISTED
Ensco Rowan plc
ESV
| $1.55M | ﹤0.01% |
37,325
-15,350
| -29% | -$627K |
|
3661
Alliance Resource Partners
ARLP
$3.31B
| $1.55M | ﹤0.01% |
132,750
-1,401,372
| -91% | -$17.1M |
|
3662
PUT
Mohawk Industries
MHK
$9.25B
| $1.55M | ﹤0.01% |
8,100
+1,700
| +27% | +$296K |
|
|
EDOM
3663
DELISTED
WisdomTree Europe Domestic Economy Fund
EDOM
| $1.55M | ﹤0.01% |
65,000
| – | – |
|
3664
Dave & Buster's
PLAY
$369M
| $1.54M | ﹤0.01% |
39,833
+27,881
| +233% | +$1.02M |
|
3665
CALL
PPG Industries
PPG
$26.2B
| $1.54M | ﹤0.01% |
13,800
+1,400
| +11% | +$138K |
|
3666
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$245M
| – | – |
0
| – | – |
|
|
SGYP
3667
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.54M | ﹤0.01% |
556,628
+220,145
| +65% | +$797K |
|
3668
Seres Therapeutics
MCRB
$50.8M
| $1.53M | ﹤0.01% |
2,880
+1,824
| +173% | +$952K |
|
3669
CALL
Inogen
INGN
$187M
| $1.53M | ﹤0.01% |
+34,000
| New | +$1.21M |
|
|
3670
PUT
Inogen
INGN
$187M
| $1.53M | ﹤0.01% |
+34,000
| New | +$1.21M |
|
|
DIVY
3671
DELISTED
Reality Shares DIVS ETF
DIVY
| $1.53M | ﹤0.01% |
66,160
+33,079
| +100% | +$758K |
|
3672
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.56B
| $1.53M | ﹤0.01% |
62,159
-24,564
| -28% | -$570K |
|
3673
PUT
Nokia
NOK
$55.4B
| $1.52M | ﹤0.01% |
256,700
+72,000
| +39% | +$461K |
|
3674
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$372M
| $1.52M | ﹤0.01% |
13,618
+96
| +0.7% | +$10.4K |
|
|
PIV
3675
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
| $1.51M | ﹤0.01% |
61,456
-659
| -1% | -$16.2K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.